Warning: The NCBI web site requires JavaScript to function. more...
Selection for resistance to oseltamivir in seasonal and pandemic H1N1 influenza and widespread co-circulation of the lineages.
Janies DA, Voronkin IO, Studer J, Hardman J, Alexandrov BB, Treseder TW, Valson C.
Int J Health Geogr. 2010 Feb 24;9:13.
Related citations
Evaluation of a rapid molecular algorithm for detection of pandemic influenza A (H1N1) 2009 virus and screening for a key oseltamivir resistance (H275Y) substitution in neuraminidase.
van der Vries E, Jonges M, Herfst S, Maaskant J, Van der Linden A, Guldemeester J, Aron GI, Bestebroer TM, Koopmans M, Meijer A, Fouchier RA, Osterhaus AD, Boucher CA, Schutten M.
J Clin Virol. 2010 Jan;47(1):34-7. Epub 2009 Oct 25.
Genetic makeup of amantadine-resistant and oseltamivir-resistant human influenza A/H1N1 viruses.
Zaraket H, Saito R, Suzuki Y, Baranovich T, Dapat C, Caperig-Dapat I, Suzuki H.
J Clin Microbiol. 2010 Apr;48(4):1085-92. Epub 2010 Feb 3.
Oseltamivir-resistant influenza virus A (H1N1), Europe, 2007-08 season.
Meijer A, Lackenby A, Hungnes O, Lina B, van-der-Werf S, Schweiger B, Opp M, Paget J, van-de-Kassteele J, Hay A, Zambon M; European Influenza Surveillance Scheme.
Emerg Infect Dis. 2009 Apr;15(4):552-60.
Oseltamivir-resistant influenza viruses circulating during the first year of the influenza A(H1N1) 2009 pandemic in the Asia-Pacific region, March 2009 to March 2010.
Hurt AC, Deng YM, Ernest J, Caldwell N, Leang L, Iannello P, Komadina N, Shaw R, Smith D, Dwyer DE, Tramontana AR, Lin RT, Freeman K, Kelso A, Barr IG.
Euro Surveill. 2011 Jan 20;16(3). pii: 19770.
Surveillance for neuraminidase inhibitor resistance among human influenza A and B viruses circulating worldwide from 2004 to 2008.
Sheu TG, Deyde VM, Okomo-Adhiambo M, Garten RJ, Xu X, Bright RA, Butler EN, Wallis TR, Klimov AI, Gubareva LV.
Antimicrob Agents Chemother. 2008 Sep;52(9):3284-92. Epub 2008 Jul 14.
Genetic characterization of circulating seasonal Influenza A viruses (2005-2009) revealed introduction of oseltamivir resistant H1N1 strains during 2009 in eastern India.
Agrawal AS, Sarkar M, Ghosh S, Roy T, Chakrabarti S, Lal R, Mishra AC, Chadha MS, Chawla-Sarkar M.
Infect Genet Evol. 2010 Dec;10(8):1188-98. Epub 2010 Aug 1.
Neuraminidase inhibitor resistance after oseltamivir treatment of acute influenza A and B in children.
Stephenson I, Democratis J, Lackenby A, McNally T, Smith J, Pareek M, Ellis J, Bermingham A, Nicholson K, Zambon M.
Clin Infect Dis. 2009 Feb 15;48(4):389-96.
Detection of the rapid emergence of the H275Y mutation associated with oseltamivir resistance in severe pandemic influenza virus A/H1N1 09 infections.
Wang B, Dwyer DE, Blyth CC, Soedjono M, Shi H, Kesson A, Ratnamohan M, McPhie K, Cunningham AL, Saksena NK.
Antiviral Res. 2010 Jul;87(1):16-21. Epub 2010 Apr 10.
Responding to pandemic (H1N1) 2009 influenza: the role of oseltamivir.
Reddy D.
J Antimicrob Chemother. 2010 Apr;65 Suppl 2:ii35-ii40. Review.
Zanamivir-resistant influenza viruses with a novel neuraminidase mutation.
Hurt AC, Holien JK, Parker M, Kelso A, Barr IG.
J Virol. 2009 Oct;83(20):10366-73. Epub 2009 Jul 29.
Novel pandemic influenza A(H1N1) viruses are potently inhibited by DAS181, a sialidase fusion protein.
Triana-Baltzer GB, Gubareva LV, Nicholls JM, Pearce MB, Mishin VP, Belser JA, Chen LM, Chan RW, Chan MC, Hedlund M, Larson JL, Moss RB, Katz JM, Tumpey TM, Fang F.
PLoS One. 2009 Nov 6;4(11):e7788.
Emerging oseltamivir resistance in seasonal and pandemic influenza A/H1N1.
Renaud C, Kuypers J, Englund JA.
J Clin Virol. 2011 Oct;52(2):70-8. Epub 2011 Jun 17. Review.
Genotypic and phenotypic resistance of pandemic A/H1N1 influenza viruses circulating in Germany.
Duwe SC, Wedde M, Birkner P, Schweiger B.
Antiviral Res. 2011 Jan;89(1):115-8. Epub 2010 Nov 9.
Pandemic influenza A(H1N1)v viruses currently circulating in New Zealand are sensitive to oseltamivir.
Hall RJ, Peacey MP, Ralston JC, Bocacao J, Ziki M, Gunn W, Quirk A, Huang QS.
Euro Surveill. 2009 Jul 30;14(30):19282.
Adamantane- and oseltamivir-resistant seasonal A (H1N1) and pandemic A (H1N1) 2009 influenza viruses in Guangdong, China, during 2008 and 2009.
Zhou J, Zou L, Zhang X, Liao J, Ni H, Hou N, Wang Y, Li H, Wu J, Jonges M, Meijer A, Koopmans M, Ke C.
J Clin Microbiol. 2011 Jul;49(7):2651-5. Epub 2011 May 18.
Emergence of H274Y oseltamivir-resistant A(H1N1) influenza viruses in Japan during the 2008-2009 season.
Baranovich T, Saito R, Suzuki Y, Zaraket H, Dapat C, Caperig-Dapat I, Oguma T, Shabana II, Saito T, Suzuki H; Japanese Influenza Collaborative Study Group.
J Clin Virol. 2010 Jan;47(1):23-8. Epub 2009 Dec 3.
Identification of oseltamivir resistance among pandemic and seasonal influenza A (H1N1) viruses by an His275Tyr genotyping assay using the cycling probe method.
Suzuki Y, Saito R, Sato I, Zaraket H, Nishikawa M, Tamura T, Dapat C, Caperig-Dapat I, Baranovich T, Suzuki T, Suzuki H.
J Clin Microbiol. 2011 Jan;49(1):125-30. Epub 2010 Nov 17.
Susceptibility of antiviral drugs against 2009 influenza A (H1N1) virus.
Rungrotmongkol T, Intharathep P, Malaisree M, Nunthaboot N, Kaiyawet N, Sompornpisut P, Payungporn S, Poovorawan Y, Hannongbua S.
Biochem Biophys Res Commun. 2009 Jul 31;385(3):390-4. Epub 2009 May 20.
Oseltamivir-resistant 2009 pandemic influenza A (H1N1) virus infection in two summer campers receiving prophylaxis--North Carolina, 2009.
Centers for Disease Control and Prevention (CDC).
MMWR Morb Mortal Wkly Rep. 2009 Sep 11;58(35):969-72.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on